Full thickness macular hole after intravitreal brolucizumab injection in neovascular age-related macular degeneration

被引：0
|
作者：
Lee, Sang Hyeok [1 ]
Lee, Mee Yon [1 ]
机构：
[1] Catholic Univ Korea, Coll Med, Dept Ophthalmol, Seoul, South Korea
来源：
EUROPEAN JOURNAL OF OPHTHALMOLOGY | 2024年
关键词：
Macular hole; anti-VEGF; brolucizumab; RETINAL-PIGMENT EPITHELIUM; RANIBIZUMAB; DETACHMENT;
D O I：
10.1177/11206721241286708
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
Purpose To describe a case of full thickness macular hole after intravitreal brolucizumab injection in neovascular age-related macular degeneration, which has not been reported to date.Case description A 65-year-old male patient received brolucizumab intravitreal injection therapy for neovascular macular degeneration of the right eye. He received multiple intravitreal anti-VEGF injections on a pro re nata regimen and developed a full thickness macular hole.Outcome Surgical treatment was performed with pars plana vitrectomy of the right eye. Full thickness macular hole was successfully treated.Conclusion Although a full thickness macular hole following intravitreal brolucizumab injection is an uncommon complication, it requires caution.
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Bilateral occlusive vasculitis after intravitreal injection of brolucizumab in neovascular age-related macular degeneration
    Riedel, Anna Maria
    Lackerbauer, Carlo
    Lohmann, Chris P.
    Ulbig, Michael
    OPHTHALMOLOGE, 2022, 119 (01): : 75 - 78
  • [2] Bilateral occlusive vasculitis after intravitreal injection of brolucizumab in neovascular age-related macular degeneration
    Riedel, Anna Maria
    Lackerbauer, Carlo
    Lohmann, Chris P.
    Ulbig, Michael
    OPHTHALMOLOGIE, 2022, 119 (01): : 75 - 78
  • [3] The effect of intravitreal brolucizumab on choroidal thickness in patients with neovascular age-related macular degeneration
    Ki Woong Bae
    Dong Ik Kim
    Daniel Duck-Jin Hwang
    Scientific Reports, 12
  • [4] The effect of intravitreal brolucizumab on choroidal thickness in patients with neovascular age-related macular degeneration
    Bae, Ki Woong
    Kim, Dong Ik
    Hwang, Daniel Duck-Jin
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [5] Clinical Outcomes of Intravitreal Brolucizumab Injection for Refractory Neovascular Age-related Macular Degeneration
    Lee, Jun Young
    Park, No Hae
    Kwon, Han Jo
    Park, Sung Who
    Byon, Ik Soo
    JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2024, 65 (09): : 596 - 604
  • [6] Intravitreal Brolucizumab for Neovascular Age-Related Macular Degeneration in a Vitrectomized Eye
    Maggio, Emilia
    Alfano, Alessandro
    Mete, Maurizio
    Pertile, Grazia
    CASE REPORTS IN OPHTHALMOLOGY, 2022, 13 (03): : 736 - 743
  • [7] Factors Affecting Disease Stability After Intravitreal Brolucizumab Injection in Refractory Neovascular Age-related Macular Degeneration
    Ji, Yong-Sok
    Kim, Yung Hui
    Kim, Hyun Jee
    Lee, Jong Hoon
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [8] Factors Affecting Disease Stability After Intravitreal Brolucizumab Injection for Refractory Neovascular Age-Related Macular Degeneration
    Kim, Yung-Hwi
    Moon, Tae Kyu
    Ji, Yong-Sok
    OPHTHALMOLOGY AND THERAPY, 2024, : 2679 - 2695
  • [9] Intravitreal brolucizumab in neovascular age-related macular degeneration with limited response to aflibercept
    Hatz, Katja B.
    Cedro, Luca
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [10] Lamellar macular hole following intravitreal aflibercept injection in a patient with neovascular age-related macular degeneration
    Bagci, Fatma
    Citirik, Mehmet
    CUKUROVA MEDICAL JOURNAL, 2023, 48 (02): : 728 - 732
12345